Literature DB >> 1224004

Effects of molindone on central dopaminergic neuronal activity and metabolism: similarity to other neuroleptics.

B S Bunney, R H Roth, G K Aghajanian.   

Abstract

The effect of molindone on the activity of dopaminergic (DA) neurons in the rat midbrain and on DA metabolism in the striatum and olfactory tubercles was studied using extracellular single unit recording and biochemical techniques respectively. Molindone in low intravenous doses (0.4-0.8 mg/kg) was found to reverse d-amphetamine and apomorphine induced depression of DA neurons and to block apomorphine induced depression of these cells. Molindone was also found to increase dopamine synthesis and dihydroxyphenylactic acid levels in the striatum and olfacotry tubercles. In all of these respects molindone behaves identically to most classical neuroleptics. However, unlike most antipsychotic drugs previously tested, molindone failed to increase the baseline firing rate of DA cells and blocked haloperidol induced increases in DA neuron activity. In this regard molindone most closely resembles thioridazine and clozapine. Possible mechanisms of action of molindone are discussed based on these findings.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1224004

Source DB:  PubMed          Journal:  Psychopharmacol Commun        ISSN: 0098-616X


  8 in total

1.  The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools.

Authors:  S E Robinson; S Berney; R Mishra; F Sulser
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

2.  Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.

Authors:  J R Walters; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

3.  Seroquel: electrophysiological profile of a potential atypical antipsychotic.

Authors:  J M Goldstein; L C Litwin; E B Sutton; J B Malick
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Pharmacologic therapeutic window of pramiracetam demonstrated in behavior, EEG, and single neuron firing rates.

Authors:  B P Poschel; P M Ho; F W Ninteman; M J Callahan
Journal:  Experientia       Date:  1985-09-15

5.  CGP 25454A, a novel and selective presynaptic dopamine autoreceptor antagonist.

Authors:  S Bischoff; P Baumann; J Krauss; L Maître; A Vassout; A Storni; G Chouinard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-09       Impact factor: 3.000

6.  Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.

Authors:  E Meller
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.

Authors:  C F Saller; A I Salama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

8.  Effects of molindone and fluphenazine on the brain concentration of some phenolic and catecholic amines in the mouse and the rat.

Authors:  A V Juorio
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.